Dry Powder Inhalers Market Growing Rapidly Huge Growth by 2031- Vectura Group plc, GlaxoSmithKline plc, AstraZeneca, Boehringer Ingelheim GmbH

The Global Dry Powder Inhalers Market is expected to grow at a CAGR of 5.1% during the forecast period 2024-2031

Dry powder inhalers (DPIs) administer medication in dry powder form to patients with respiratory conditions. They are increasingly favored over pressurized metered dose inhalers (P-MDIs) due to environmental concerns about the use of chlorofluorocarbon (CFC) propellants in P-MDIs.

Get a Free Sample Research PDF: https://www.datamintelligence.com/download-sample/dry-powder-inhalers-market

Market Dynamics:

Technological advancements are expected to drive market growth, addressing the limitations of traditional treatments like delayed onset and low efficacy. For example, in February 2021, Sanofi, in collaboration with Regeneron Pharmaceuticals, launched a Phase III clinical trial to evaluate the safety and efficacy of itepekimab for COPD. Additionally, companies are expanding through product launches and collaborations, such as Lonza's Center of Excellence for Dry Powder Inhaler (DPI) drug development in July 2020. The increasing global geriatric population and rising COPD cases further boost market growth.

Market Segment:

By Product Type: Capsule Based Devices, Blister Based Devices, Reservoir/Cartridge Based Devices, Others

By Indication Type: Bronchitis, Chronic Obstructive Pulmonary Diseases (Copd), Asthma, Others

Get Customization in the report as per your requierments: https://www.datamintelligence.com/customize/dry-powder-inhalers-market

Regional Analysis:

The global dry powder inhalers market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

The global dry powder inhalers market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The dry powder inhalers market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Major Key Players:

• Vectura Group plc
• GlaxoSmithKline plc
• AstraZeneca
• Boehringer Ingelheim GmbH
• Otsuka Pharmaceutical Co. Ltd
• Norton Healthcare
• Respira Therapeutics, Inc
• Boehringer Ingelheim
• Chiesi
• Cipla

*Note:

Additionally, I wanted to highlight that the full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted.

Related Reports:

Sterilization Equipment Market: https://www.datamintelligence.com/research-report/sterilization-equipment-market

Implantable Infusion Pumps Market: https://www.datamintelligence.com/research-report/implantable-infusion-pumps-market

Hazardous Drug Administration Market: https://www.datamintelligence.com/research-report/hazardous-drug-administration-market

Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.